Care
The platform assesses cognitive and motor function via at-home assessments that generate digital biomarkers and a predictive score, supporting the early detection of Parkinson's.
Researchers at Johns Hopkins found that the AI outperformed current clinical guidelines with 89% accuracy across all patients and a 93% accuracy rate for individuals ages 40 to 60.
Also, a project developing an AI-powered application for preventing cognitive decline among seniors has won a $2 million grant from the New Zealand government.
Also, OMRON in Singapore has launched a new medical device plan featuring AI-driven recommendations for self-management of chronic diseases.
Users of XRHealth's immersive therapeutic platform will be able to receive real-time movement analysis feedback during rehabilitation.
The company will use the funds to develop its employee assistance program platform, expand global clinical access and increase partnerships.
The UroNav system uses MRI and ultrasound images for more precise, minimally invasive care.
Pregnant and postpartum patients will have access to an app and educational programs to help them develop skills to manage the challenges of pregnancy and parenthood.
Anervea.ai will develop and deploy an AI-powered suite of applications on Komodo's MapLab Enterprise platform.
The oncology-focused company will use the funds to boost manufacturing capacity, grow its commercial team and develop its next-generation Amma product.